C-peptide, a 31–amino acid peptide originally regarded as an inert by‐product of insulin synthesis, is emerging as a key modulator of diabetic complications. Secreted in equimolar amounts with insulin ...
MINNEAPOLIS, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet ...
Insulinoma sequencing shows chromosomal aberrations but no driver mutations, suggesting the long-term effects of congenital glucose-galactose malabsorption.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback